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Abstract
Background: Regulatory regions (e.g. promoters and enhancers) play an essential role in human development and
disease. Many computational approaches have been developed to predict the regulatory regions using various
genomic features such as sequence motifs and evolutionary conservation. However, these DNA sequence-based
approaches do not reflect the tissue-specific nature of the regulatory regions. In this work, we propose to predict
regulatory regions using multiple features derived from DNA methylation profile.
Results: We discovered several interesting features of the methylated CpG (mCpG) sites within regulatory regions.
First, a hypomethylation status of CpGs within regulatory regions, compared to the genomic background
methylation level, extended out >1000 bp from the center of the regulatory regions, demonstrating a high degree
of correlation between the methylation statuses of neighboring mCpG sites. Second, when a regulatory region was
inactive, as determined by histone mark differences between cell lines, methylation level of the mCpG site
increased from a hypomethylated state to a hypermethylated state, the level of which was even higher than the
genomic background. Third, a distinct set of sequence motifs was overrepresented surrounding mCpG sites within
regulatory regions. Using 5 types of features derived from DNA methylation profiles, we were able to predict
promoters and enhancers using machine-learning approach (support vector machine). The performances for
prediction of promoters and enhancers are quite well, showing an area under the ROC curve (AUC) of 0.992 and
0.817, respectively, which is better than that simply based on methylation level, especially for prediction of
enhancers.
Conclusions: Our study suggests that DNA methylation features of mCpG sites can be used to predict regulatory
regions.
Introduction
Transcriptional regulation plays an important role in
most of biological processes. The interactions between
transcription factors and regulatory regions, such as pro-
moters and enhancers, are essential in transcriptional
regulation. Therefore, identification of regulatory regions
will provide mechanistic insight into various biological
processes. Experimental and computational approaches
have been developed to identify the regulatory regions on
a genome-wide scale. For example, evolutionary
conservation, sequence motifs, and clustering of tran-
scription factor binding motifs (or cis-regulatory mod-
ules) can be used to predict regulatory regions [1-4].
However, these approaches are based purely on DNA
sequences, which do not reflect the tissue-specific nature
of the regulatory regions.
Recently, histone marks were measured on a genome-
wide scale using the ChIP-seq technique [5-7]. These his-
tone marks are good predictors for regulatory regions. For
example, H3K4me1 is associated with active enhancers,
while H3K4me3 is related to active promoters [8]. In addi-
tion, DNase I hypersensitivity sites (DHS) also localize to
open chromatin regions, which are likely regulatory
regions [9,10]. The ENCODE project has generated
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histone marks and DHS profiles in multiple cell lines and
tissues [8,9,11,12], which provide valuable information to
understand the organization and dynamics of the regula-
tory regions in the cells.
In this work, we propose to predict regulatory regions by
utilizing the DNA methylation patterns. DNA methylation,
the addition of a methyl group to the fifth carbon of a
cytosine residue adjacent to a guanine (a CpG site), is a
well-studied epigenetic modification. While DNA methyla-
tion is considered stable and heritable in differentiated
somatic cells, it can also change dynamically during the
lifespan of a cell and is susceptible to diet and other envir-
onmental influences [13,14]. DNA methylation is known
to play a role in gene regulation. It is well accepted that
DNA methylation in promoter regions represses the
expression of the genes [15]. High-throughput technolo-
gies, such as whole genome bisulfite sequencing and
array-based methods, have enabled the mapping of DNA
methylation patterns on a genomic scale, identifying hun-
dreds of millions of methylated cytosines [16-19].
DNA methylation-based approach has been developed to
predict regulatory regions in recent work [20,21]. In these
studies, low methylation regions are associated with distal
regulatory elements, as they are enriched for active histone
marks (e.g. H3K4me1), DNase-hypersensitive sites, and
transcription factor binding sites (TFBS). In this study, we
performed a comprehensive survey of mCpGs in regulatory
regions and explore whether we can extract a set of DNA
methylation dependent features besides the methylation
level to improve the prediction. By examining these prop-
erties of the mCpG sites across different cell lines, we dis-
covered that these sites did demonstrate specific genomic
properties. Using these genomic features, we were able to
predict regulatory regions using support vector machine
approach. The paper is organized as follows. We first
defined the positive and negative sets for regulatory region
prediction. We then described the novel features derived
from DNA methylation profiles. Finally, we utilized
machine-learning approach (support vector machine) to
predict regulatory regions (promoters and enhancers sepa-
rately) based on the features we obtained. Our results
demonstrate that the performance of the prediction based
on multiple DNA methylation-associated features is better
than the prediction solely based on methylation level.
Results
Selection and assessment of positive and negative
datasets
We used the previously established definition of a regu-
latory region as determined by genome-wide histone
modification signatures [8]. For example, H3K4me3 is
known to be associated with promoters, while H3K4me1
with enhancers. Ernst et al. predicted different types of
regulatory regions using a hidden Markov model. In this
paper, we focus on two major regulatory regions: pro-
moters and enhancers.
We also selected the same numbers of the mCpG sites
in random genomic regions as negative datasets. To
exclude the effect of differential methylation due to
genomic location, we chose random genomic regions
with the same relative distance to the nearest transcrip-
tion start site (TSS) or exon-intron boundary for each
type of regulatory regions (see Methods for details).
To determine the quality of the regulatory regions
determined by histone marks, we calculated the correla-
tion between the methylation level of a mCpG site and
the expression of its associated target genes (Figure 1A).
The adjacent gene of a promoter was selected as its target
gene. The predicted target genes for enhancers were
obtained from Thurman et al. [9], which is based on the
correlation of DNase I hypersensitivity activity between
distal elements and promoters across cell lines. For each
methylation site, Pearson correlation coefficient was used
to compute the correlation between methylation level at
a given site and the expression of its target gene across
cell lines [22]. As comparison, the same correlation was
calculated for the negative datasets.
Compared to the mCpG sites in random genomic
regions, the methylation level of the mCpG sites in the
regulatory regions was significantly more negatively cor-
related with the expression of the target genes (p <
1.0E-15; Kolmogorov-Smirnov test) (Figure 1B and
Figure 1C). This is consistent with the notion that DNA
methylation represses gene expression. We would like to
point out that the conclusion still holds if we used
Spearman’s rank correlation, rather than Pearson corre-
lation coefficient (Additional file 1: Figure. S1A, B).
Overall, our result suggests that the regulatory regions
predicted by histone marks and the random genomic
regions with similar relative genomic locations are of
reasonable quality and are suitable to serve as the posi-
tive and negative sets of this study.
mCpGs in regulatory regions are hypomethylated
We then extract a series of DNA methylation-dependent
features by comparing the methylation sites in the regu-
latory regions and random mCpG sites in the negative
sets. We found that the methylation level of regulatory
mCpG sites was significantly lower than the other
mCpG sites (Figure 2). The average methylation levels
of mCpGs in active promoters and the corresponding
negative set are 0.34 and 0.72, respectively, showing sta-
tistically significant difference (p < 1.0E-15 based on
Kolmogorov-Smirnov test). Similarly, the methylation
levels of mCpGs in strong enhancers and the corre-
sponding negative sets are 0.69 and 0.84, respectively
(p < 1.0E-15 based on Kolmogorov-Smirnov test). These
results persisted when CpG islands in the regulatory
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regions and the corresponding random regions were
excluded, indicating that the low methylation level in
regulatory regions was not due to the overlap with CpG
islands, which are generally hypomethylated (Figure 2B,
2C). Interestingly, regulatory regions overlapping with
CpG islands demonstrated lower methylation levels than
regulatory regions outside of the CpG islands (p < 1.0E-15
based on Kolmogorov-Smirnov test; Figure 2B, 2C), sug-
gesting that those CpG islands playing a regulatory role
have lower methylation levels. Overall, our observations
suggested that hypomethylation is a key feature of regula-
tory regions, independent of the relative location to a CpG
island.
Hypomethylation in regulatory regions extends across a
long range
Within a methylated regulatory region, the lowest
methylation level is found centrally within the region,
Figure 1 The regulatory regions predicted by histone marks are likely to be functional. (A) Correlation between methylation level of a
mCpG and its target gene’s expression. (B-C) Distribution of correlation between methylation level of mCpGs and their target genes’ expression
in regulatory regions and random regions. mCpGs in regulatory regions are hypomethylated.
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and this hypomethylation extends across a long range
(Figure 3). For example, the average methylation level of
mCpGs at the center of active promoters (0.34) gradu-
ally increases across the promoter region and reaches a
plateau (0.82) at ~1500 bp away, suggesting that hypo-
methylation is not localized to a narrow genomic region
(Figure 3A). The extended hypomethylated regions were
also apparent within strong enhancers (Figure 3B).
Strikingly, the extended hypomethylation was also
observed within transcription factor (TF) binding sites,
which are generally more localized to 10-20 bp regions.
Using ChIP-seq and predicted data for several TFs [23],
we found that the methylation levels were lowest in the
center of TF binding sites and reached background level
by 1500 bp (Figure 3C), despite the fact that the major-
ity of binding sites are less than 20 bp in length.
Figure 2 CpG sites are hypomethylated in regulatory regions. (A) Methylation level distribution of mCpGs in regulatory regions (blue and
black) and random regions (grey). (B-C) Methylation level distribution of mCpGs inside and outside of CpG islands for regulatory regions (blue
and black) and random regions (grey).
Hwang et al. BMC Genomics 2015, 16(Suppl 7):S11
http://www.biomedcentral.com/1471-2164/16/S7/S11
Page 4 of 13
Methylation levels of neighboring regulatory mCpG sites
are highly correlated
One explanation of the extended hypomethylation is corre-
lation between neighboring regulatory mCpG sites. To test
this hypothesis, we calculated the autocorrelation of
methylation profiles within regulatory regions. Specifically,
we computed the correlation of methylation levels at two
methylation sites as a function of their genomic distances
(Figure 3D, see Methods for detail). As expected, mCpG
sites within close proximity showed higher correlation than
those located distally. Based on the autocorrelation of
methylation profile, we observed that the correlation of
methylation between mCpG sites was significantly stronger
in regulatory regions than in non-regulatory regions (p <
1.0E-15 based on Kolmogorov-Smirnov test; Figure 3D). In
regulatory regions, the correlation of methylation levels
extended across distances of up to 326 and 231bp for pro-
moters and enhancers, respectively, whilst in random geno-
mic regions the correlation disappeared by 41bp (see also
Additional file 1: Figure S1C).
We speculated that a high density of CpG sites could
be the underlying mechanism for correlation between
Figure 3 The hypomethylation in regulatory regions extends a long range. (A-C) Average methylation level of mCpGs in regulatory regions
and random regions. The regions were aligned on their center position. × axis is the distance from the center of the regions. Y axis is the
average methylation level. (D) Autocorrelation between two mCpGs in regulatory regions and random regions. × axis is distance between two
mCpGs. (E) CpG density of regulatory regions and random regions.
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methylation levels, as sites in close proximity might be
co-regulated by DNA methyltransferases. We examined
the CpG densities in the regulatory and random regions
and found that regulatory CpG sites were much denser
than those in random regions, especially within active
promoters (Figure 3E). This observation was true even if
the CpG islands in these regions were excluded (Addi-
tional file 1: Figs S1D, E). Thus, the hypomethylation in
regulatory regions and/or TF binding sites can be attrib-
uted to both the high correlation between methylation
levels and the high CpG density within these regions.
Inactive regulatory regions are hypermethylated
Epigenetic marks in regulatory regions differ between
different cell types. For example, in a given cell line a
genomic region can be an active promoter enriched for
active histone marks (e.g. H3K4me3, H3K9ac, and
H3K27ac), while the same region may be inactive in
another cell line due to the absence of such histone
marks. To address the role of histone modifications
within regulatory regions, we compared changes in the
methylation level of the regulatory mCpG sites to
changes in histone mark status. The methylation levels
between two cell lines (H1 and GM12878) were exam-
ined, as genome-wide histone modification and methyla-
tion data were available for both cell lines. We defined
three genomic regions for each cell line: transcription-
ally active, transcriptionally inactive, and random (back-
ground) regions. For example, the genomic regions
predicted as regulatory regions in H1 cell were defined
as ‘active’ in H1 cell. The genomic regions that were
predicted as regulatory regions in GM12878 cell, but
not in H1 cell were categorized as ‘inactive’ in H1 cell.
These “inactive” regions represent the genomic regions
that are not enriched by transcriptionally active histone
marks in H1, but have the potential to become tran-
scriptional active in other cell lines. As comparison, we
also selected a set of genomic regions that do not over-
lap with any regulatory region in both H1 and
GM12878 (see details in Methods and Figure 4A). The
mCpGs methylation levels inside active, inactive, and
random regions in H1 cell were compared.
Using our comparative analysis between H1 and
GM12878 cells, we found that the methylation levels at
mCpG sites within inactive promoters and enhancers
resembled neither the active nor the background (random
region) levels (Figure 4B). Interestingly, the methylation
levels in inactive regulatory regions were even higher than
background levels obtained from random regions (p <
1.0E-15; Kolmogorov-Smirnov test) (Figure 4B). This phe-
nomenon was robust as it was present when we compared
H1 cells with other different cell lines (additional file: 2:
Figure S2 A-E). Furthermore, the finding still held if we
grouped the regulatory regions based on whether they
overlap with CpG islands (Figure 4B, additional file 2:
Figs S2 A-E, 3: Figure. S3). Finally, rather than using pre-
dicted active and inactive regulatory regions, if we used the
raw histone marks (e.g. H3k9ac), we made the same obser-
vation in multiple cell lines (Additional file 4: Figure S4).
Our findings demonstrate that inactive regulatory regions
show hypermethylation relative to the genomic back-
ground, distinguishing inactive regulatory regions from
background methylation.
Methylation level in regulatory regions can vary
considerably between cells
The difference in methylation levels between active and
inactive regions suggested that regulatory mCpG sites
might have a greater range of possible methylation levels
than other mCpGs. To test this hypothesis, we calcu-
lated the variability of each mCpG site across the cell
lines whose genome-wide methylation profiles are publi-
cally available [22]. The variance of the methylation
levels for the regulatory regions predicted in H1 cells
were then compared to those from random genomic
regions (Figure 4C, 4D). About 40% of the regulatory
mCpG sites have a variance larger than 0.2, whereas
only 15% of mCpG sites in other genomic regions
showed the same variance, suggesting that the regula-
tory mCpG sites have a larger range of potential methy-
lation levels.
We then directly related the methylation level of
mCpGs to the regulatory state (active versus inactive).
For those mCpG sites that were present in an active
regulatory region in both cell lines, the difference in
methylation level between the two cell lines was small
(Additional file 2: Fig. S2F). In fact, the vast majority
(~75%) of the regulatory mCpG sites showed very small
methylation level differences in the range of -0.1 to 0.1
between the two different cell lines. This difference was
similar to the difference in methylation levels of mCpG
sites in random genomic regions. In contrast, the regula-
tory mCpG sites present in both active and inactive reg-
ulatory regions in two cell lines showed a greater
methylation difference; less than a half (42%) of the
active-inactive regulatory regions had methylation level
differences between -0.1 and 0.1. Taken together, the
large range of potential methylation levels in the regula-
tory regions can be associated with the status changes
of the regulatory regions.
Distinct sequence motifs are associated with regulatory
mCpG sites
Since DNA motifs were used to predict enhancers, we also
explore to identify the DNA motifs associated with mCpG
sites in regulatory regions. The rationale is that DNA
methylation is believed to play a crucial role in the tran-
scription process by directly interfering with TF binding to
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the regulatory regions [24]. Therefore, we hypothesize that
sequence motifs around the mCpGs in regulatory regions
were more likely to be TF binding sites and would serve as
another informative feature distinguishing regulatory
mCpG sites. We examined all 8-mer sequences with a
CpG in the center and compared the occurrence of each
motif in the regulatory regions and in the random regions.
The statistical significance of each motif was evaluated,
and both overrepresented and underrepresented motifs
were identified. In total, 86 and 194 8-mers were signifi-
cantly overrepresented in the active promoters and the
strong enhancers, respectively, compared to background
(p < 1.0E-5). Additionally, we found 104 and 86 signifi-
cantly underrepresented 8-mers in the active promoter and
the strong enhancers (p < 1.0E-5). Figure 5 lists the top 5
most significantly overrepresented and underrepresented
8-mers in the regulatory regions (see additional file 5:
Fig. S5 for additional motifs). These motifs were also
compared with known transcription factor consensus
sequences (5: Figure. S5).
Interestingly, the nucleotide composition of the over-
represented 8-mers was different from that of the
underrepresented 8-mers. For example, the GC content
of overrepresented 8-mers obtained from the promoters
and enhancers are 0.68 and 0.60, respectively. In con-
trast, the GC contents of the underrepresented 8-mers
from the promoters and enhancers are only 0.47 and
0.31, respectively. This distinct nucleotide composition
difference became more significant when considering
only the 2 bases directly adjacent to the CpG sites. Over
77% and 68% of the overrepresented 8-mers in the pro-
moters and enhancers, respectively, had either cytosines
Figure 4 Methylation level changes with the regulatory region status. (A) Functional status changes of a genomic region among different
cells. A region can be active (green) in a cell (H1) while inactive (purple) in another cell (Gm12878). (B) Methylation level distribution of mCpGs
inside of CpG islands in active, inactive and random regions. (C-D) Methylation level variance of mCpGs in regulatory and random regions
among 15 cell lines.
Hwang et al. BMC Genomics 2015, 16(Suppl 7):S11
http://www.biomedcentral.com/1471-2164/16/S7/S11
Page 7 of 13
or guanines as a direct neighbor of the CpG site. In
contrast, only 31% and 28% of the underrepresented 8-
mers in these two types of regulatory regions had either
cytosines or guanines at these positions. Cytosines or
guanines were simultaneously observed in both direct
neighbors of the overrepresented motifs (56% and 45%
in the promoters and enhancers, respectively), which
occur much less frequently in the underrepresented
Figure 5 DNA Motifs are associated with CpG sites in regulatory regions. 5 most significantly overrepresented and underrepresented
sequence motifs surrounding mCpGs in regulatory regions. Third and fourth column show the sequence logos and the names of the best
matched transcriptional factor binding sites. (A) Active promoter (B) Strong enhancer
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motifs (13% and 11% in the promoters and enhancers,
respectively).
Regulatory regions are predictable
Distinct genomic features of the regulatory mCpGs,
which distinguish them from other mCpGs in negative
sets, were used to predict regulatory regions. We pre-
dicted the regulatory regions using these features, includ-
ing methylation level, CpG density, autocorrelation of
methylation levels, variance of methylation levels among
different cell lines and sequence motifs (significance (-log
(P)) of the occurrence of 8-mer sequence motifs sur-
rounding the mCpGs). The computation of these features
is described in detail in Methods section. As comparison,
we predicted the regulatory regions solely based on
methylation level.
Support vector machine (SVM) was used to classify
regulatory and non-regulatory regions. SVM finds a set
of hyper planes that separates data points into a set of
classes in high dimensional feature space. To distin-
guish between regulatory and random genomic regions,
10-fold cross validation was used to measure the classi-
fication performance, in which 90% of regions were
used to train the model, and the remaining 10% of
regions were used as test dataset (see details in Meth-
ods). Figure 6A illustrated the performance of the pre-
diction for active promoters and strong enhancers
using a Receiver Operating Characteristic (ROC) curve.
The area under the ROC curve (AUC) was used to
depict the performance of a binary classification. Active
promoters and strong enhancers were predicted quite
well, showing an AUC of 0.992 and 0.817, respectively
(Figure 6A). Perhaps not surprisingly, if we only used
the methylation levels as the feature for prediction, the
performance is lower, with AUC of 0.985 and 0.692 for
promoters and enhancers, respectively. The prediction
for enhancers is significantly improved with the addi-
tional features.
Figure 6 Regulatory regions can be predicted using the features derived from DNA methylation profiles. (A) Receiver operation
characteristic curve (ROC) of regulatory region prediction using methylation profile in the regions. Support vector machine (SVM) was used. (B)
Information gain of features in the prediction.
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Some features showed more significant contribution to
the prediction than other features. Therefore, the ability of
each feature to discriminate regulatory and non-regulatory
regions was analyzed by the information gain of each fea-
ture (Figure 6B). Information gain (IG) of a given feature
F with respect to the classes (e.g., regulatory or random
regions) is the entropy reduction of the sample set when
we know the feature F (see Methods in detail). Interest-
ingly, the most informative features are different when
predicting promoters and enhancers. For the promoters,
the features showing the largest information gain are
methylation level and methylation variance, while for
enhancers, the most useful features are CpG density and
methylation autocorrelation (Figure 6B). Some features
show strikingly different contribution in predicting pro-
moters and enhances. For example, the feature of methyla-
tion variance is quite informative in promoter prediction,
with information gain of 0.67, while it has limited contri-
bution when predicting enhancers, with information gain
of 0.06. This result suggests that a set of methylation-asso-
ciated features are needed for predicting regulatory regions
and these features have different predictive power for pro-
moters and enhancers.
Discussion
Although low methylation has been found to be associated
with regulatory regions [16,21], we found that a low methy-
lation level was not sufficient to predict regulatory regions,
especially for enhancers. Additional features of mCpG sites
were required to predict regulatory regions, and we were
able to elucidate some of these features and successfully use
them for prediction. For example, in regulatory regions, we
found that a low methylation level extended across a range
that was often longer than 1000 bp, and that the correlation
of methylation levels between methylation sites was much
stronger than outside of regulatory regions. Furthermore,
we found a larger variation in methylation levels within reg-
ulatory regions compared to non-regulatory regions. There-
fore, our work provides novel insights regarding the DNA
methylation status in regulatory regions.
Since CpG islands are often lowly (or not at all)
methylated and are considered to play an important role
in gene regulation, the hypomethylated state is regarded
to be important in positive gene regulation. In this
study, we found that regulatory mCpG sites demonstrate
distinct features beside hypomethylation. Specifically, we
found that the methylation levels are highly correlated
between neighboring mCpG sites in regulatory regions.
Furthermore, when regulatory regions are inactive in
other cell types, these methylation levels did not simply
return to the background level but were instead hyper-
methylated, suggesting that in regulatory regions, a
higher level of methylation is required to maintain an
inactive state.
Correlation of the DNA methylation status of neigh-
boring CpG sites [25,26] has been previously observed;
however, in these studies, the correlation was not ana-
lyzed in the context of regulatory regions. For example,
Eckhardt et al. found an overall correlation between
neighboring CpG sites in the human genome [25]. Our
work revealed that the correlation primarily stems from
the regulatory regions as the correlation in regulatory
regions was much stronger than that in random genomic
regions.
The overrepresented 8-mer motifs in regulatory
regions are predicted as potential transcription factor
binding sites. Our prediction suggested a distinct set of
transcription factors might interact with these motifs in
a methylation-dependent fashion since the overrepre-
sented motifs had a higher GC content. While the chro-
matin structure was previously considered as one
mediator of transcription factor-DNA interaction, our
finding indicates that DNA methylation can also serve
as a “switch” for protein-DNA interactions [27,28].
Indeed, the chromatin structure and DNA methylation
can influence each other. For example, nucleosome
occupancy can direct DNA methylation [29,30], and in
some cases, DNA methylation can determine nucleo-
some occupancy [31].
In this study, we demonstrated that regulatory
regions are predictable by their methylation patterns;
however, our prediction did not perfectly separate reg-
ulatory and non-regulatory regions, especially at enhan-
cers. One possible reason is that we did not have
sufficient methylome datasets for the prediction model.
Since these behaviors required methylation levels from
multiple cell types, additional methylation data from a
range of cell types should help to better describe these
distinctive behaviors. We expect such datasets will
become available in near future and will enable better
prediction of the enhancers. Another possibility is that
DNA methylation is also associated with other func-
tional elements other than promoters and enhancers.
For example, recent studies suggested that DNA
methylation is also involved in alternative splicing reg-
ulation [32-34]. We need additional information to dis-
tinguish different types of functional elements to
improve our prediction.
Conclusion
We proposed a set of novel methylation associated fea-
tures that are informative to predict regulatory regions.
These features greatly improve the prediction compared
to the prediction solely based on methylation level. Our
results suggest that the regulatory “grammar” is encoded
in complex DNA methylation patterns and identification
of these features will provide biological insight on the
methylation-mediated gene regulation.
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Methods
Data
Human DNA methylation data as measured by bisulfite
sequencing or Illumina 450k array available for 15 cell
lines was obtained from SALK and ENCODE databases.
The regulatory regions predicted from chromatin marks
were downloaded from ENCODE database [35]. Gene
expression data by RNA-Seq, available in 4 cell lines, was
imported from SALK database [16]. RPKM (Reads per kilo
base per million) values was used for transcripts’ expres-
sion [36]. Transcription factor binding is based on ChiP-
seq or computational predictions [23,35]. Gene annotation
from UCSC Genome database was used [37].
CpG sites in the study
The methylation level of a CpG site was measured as
the ratio of the number of methylated cytosines to the
total number of sequences on that position in the bisul-
fite sequencing data. To take into account only the sites
with reliable measurement, we only consider the CpG
sites covered with more than 4 sequences.
Random region selection
Only the mCpGs in the coding regions and the upstream
regions of genes were considered, where the upstream
region of a gene was defined as the 10 kb region upstream
of the gene transcription start site (TSS). The immediate
downstream gene was classified as the target gene for
those identified mCpGs. To exclude the effect of differen-
tial methylation due to different genomic regions, we
selected random regions with similar genomic positions as
mCpG sites. For a regulatory region in the upstream
region, we selected the corresponding random regions
with the same relative distance to the TSS (Figure 7A).
Here the relative distance to the TSS was measured as the
actual distance normalized by the total length of the cod-
ing region and the upstream region of the gene. For a reg-
ulatory region in an exon or an intron region, we selected
the corresponding random regions with the same relative
distance to the nearest boundary of the exon or intron of
the target gene. Here the relative distance was normalized
by the length of the exon or intron, depending on whether
the region of interest is on exon or intron (Figure 7B).
1000 random region selections for each regulatory region
were performed in this study.
Autocorrelation of methylation profile
Methylation level autocorrelation was computed as follows:
rk =
∑N−k
i=1 (xi − x)(xi+k − x)∑N
i=1 (xi − x)2
(1)
where xi is methylation level of a mCpG at position
i, xi+k is methylation level of the mCpG distant k
nucleotides from position i, and x is mean methylation
level of the mCpGs in all regions of interest. We consid-
ered the autocorrelation disappeared when the value
reached 0.05.
CpG density and CG content
CpG density was calculated as the number of CpGs in a
region normalized by its length. CG content in a region
was measured as the number of cytosines and guanines
in the region normalized by its total length.
Sequence motif discovery
Only the 8-mer sequences with CpG in the center were
considered. An 8-mer and its reverse complement were
Figure 7 Schematic view of random region selection
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counted as the same motif. In theory, we have total
2080 possible 8-mers with CpG in the center. For each
motif, we calculated the occurrences of the motif in reg-
ulatory regions (either promoter or enhancer), and com-
pared the occurrences of the same motifs in the random
genomic regions. P-value for each 8-mers was calculated
based on binomial distribution using the occurrence
probability in the random regions as background prob-
ability.







pi(1 − p)n−i (2)
where p is probability that an 8-mer is found in the
random regions, and k is the number of occurrences of
the 8-mer of interest and n is the number of all 8-mers
in the regulatory regions. P-value was corrected for mul-
tiple testing using Bonferroni method.
Regulatory region prediction
Support Vector Machine (SVM) was used to predict reg-
ulatory regions based on the genomic features of the
mCpGs in the regions. To apply SVM to our dataset, a
number of features that represent the entities (regions) in
the dataset should be identified and transformed into fea-
ture vectors, i.e. multi-dimensional vectors in which each
element is a selected feature. SVM builds a set of hyper-
planes that separate the entities into specified classes uti-
lizing the provided feature vectors. In this research, the
test data set for prediction includes the predicted regula-
tory regions and the same number of random regions
generated as we described in the previous section. Five
features were used to form the feature vector, including
mean methylation level, mean methylation variance
among 15 cell lines, mean methylation level autocorrela-
tion between two mCpGs, CpG density, and 8-mer
sequence motif P-value around mCpGs in a genomic
region. 10-fold cross validation was used to measure the
prediction accuracy. In k-fold cross validation, the dataset
is randomly partitioned into k equal size of subsets. k-1
subsets are used to train the prediction model and the
remaining 1 subset is used to test the model. This cross
validation process is repeated k times for each subset. For
the SVM, polynomial kernel with the soft margin of 10
and the degree of 2 was used. The area under the ROC
curve (AUC) was used to evaluate the prediction
performance.
Information gain
Contribution of a feature F in the classification for a
sample set S was calculated as the information gain of S
given the feature F, i.e., the difference between the
entropy of S without any feature knowledge and the
entropy of S given the feature F.





S is a set of samples, F is a feature, IG(S,F) is informa-
tion gain for a set S given a feature F, values(F) is the
set of all possible values of an attribute F, Sv is the sub-
set of S that has value v for an attribute F, and H(S) is





where pi is the probability that a sample in S is classi-
fied as class i. Discretization was adapted for continuous
attributes.
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